A prognostic model for overall survival in recurrent glioma patients treated with bevacizumab-containing therapy.
Jin S, Chen W, Guo X, Xing H, Yang H, Liu Q, Liu D, Zhang K, Wang H, Xia Y, Guo S, Wang Y, Shi Y, Li Y, Wang Y, Li J, Wu J, Liang T, Qu T, Li H, Yang T, Wang Y, Ma W.
Jin S, et al. Among authors: wang h, wang y.
Discov Oncol. 2024 Mar 22;15(1):85. doi: 10.1007/s12672-024-00944-y.
Discov Oncol. 2024.
PMID: 38517553
Free PMC article.